Tag Archives: NUVA

Needham Reiterates a Buy Rating on NuVasive (NUVA)

Needham analyst Michael Matson reiterated a Buy rating on NuVasive (NASDAQ: NUVA) today and set a price target of $80. The company’s shares closed yesterday at $67.56. Matson noted: “We believe that new products, improved biologics growth, easing comps, and

NuVasive Receives a Hold from Cantor Fitzgerald

In a report released yesterday, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on NuVasive (NASDAQ: NUVA), with a price target of $58. The company’s shares closed yesterday at $58.05. Bijou observed: “: We maintain our Neutral rating on

A Director at NuVasive (NASDAQ: NUVA) is Buying Shares

Today, a Director at NuVasive (NASDAQ: NUVA), Peter C. Farrell, bought shares of NUVA for $236.7K. Following this transaction Peter C. Farrell’s holding in the company was increased by 180.64% to a total of $1.83 million. Following Peter C. Farrell’s

Needham Maintains a Buy Rating on NuVasive

In a report released today, Michael Matson from Needham maintained a Buy rating on NuVasive (NASDAQ: NUVA), with a price target of $69. The company’s shares closed yesterday at $53.14. Matson noted: “NUVA’s 1Q18 revenue beat and EPS missed consensus.

NuVasive Gets a Buy Rating from BTIG

BTIG analyst Ryan Zimmerman maintained a Buy rating on NuVasive (NASDAQ: NUVA) yesterday and set a price target of $72. The company’s shares closed yesterday at $53.14. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of

The Chairman & CEO of NuVasive (NASDAQ: NUVA) is Buying Shares

Today, the Chairman & CEO of NuVasive (NASDAQ: NUVA), Gregory Lucier, bought shares of NUVA for $291.4K. Following this transaction Gregory Lucier’s holding in the company was increased by 4.63% to a total of $6.69 million. Based on NuVasive’s latest